---
title: CancerIQ CEO, Feyi Olopade featured Alumni at St. Paul's School
description: CancerIQ CEO, Feyi Olopade, featured alumni of the St. Paul's school
image: https://blog.canceriq.com/hubfs/DSC_0407.jpg
---

[![CancerIQ Logo](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445848522956.png)](https://www.canceriq.com/)

[![](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445848522956.png)](https://www.canceriq.com/)

**

Our Locations

Chicago

**

Email Address

info@cancer-iq.com

# CancerIQ CEO, Feyi Olopade featured Alumni at St. Paul's School

**November 25, 2016-** What if, as part of your routine well visit to your primary care physician, you could track your predispositions – genetic and otherwise – for developing cancer? 

![DSC_0407.jpg](https://blog.canceriq.com/hs-fs/hubfs/DSC_0407.jpg?width=217&name=DSC_0407.jpg)

The idea of routine preventive care for cancer is something [CancerIQ](https://www.canceriq.com/) co-founder and CEO Feyi Olopade ’01 is working to make a reality.

 

Olopade founded the company in 2014 with her mother, renowned breast cancer doctor Funmi Olopade. Feyi’s background includes business school at Wharton and stints in investment banking and private equity. Eager to combine her entrepreneurial spirit with a social impact issue, the younger Olopade partnered with her mother to develop CancerIQ, a clinical decision support tool that helps physicians identify potential risk factors for their patients and arms those patients with the personal healthcare options necessary to intervene.

 

[*Continue to St. Paul's School website to read more about Feyi's journey as an entrepreneur. *](https://www.sps.edu/page/news-detail?pk=893589&fromId=222365)

 

![CancerIQ Logo 3](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445840775293.png)

CancerIQ makes it easy for providers to offer genetic cancer risk assessment programming to every patient that walks through the door. Our suite of patient engagement tools and productivity solutions make it easy for any busy healthcare system to start, run, and grow a highly impactful cancer risk program at lower costs.

### Contact Us

Please feel free to reach out to us:

**515 N. State, Suite 1075, Chicago, 60654 Illinois

**+312-761-3360

** info@cancer-iq.com

Cancer IQ, Inc. 2019